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A B S T R A C T
Multicystic adenomatoid hamartoma is an extremely rare tumor of the pancreas, with only 4 other cases re-
ported in the literature. We report a case of a 4-year old boy who presented with an 8 month history of ab-
dominal pain, steatorrhea, and failure to thrive. Work-up showed severe pancreatic insufficiency and a large,
multiseptated, cystic mass originating from the head of the pancreas and compressing the duodenum. The child
underwent a classic pancreaticoduodenectomy with portal vein reconstruction. He tolerated the procedure well
and has been seen in follow-up.
1. Introduction
Tumors of the pancreas are uncommon in children [1]. A review
conducted by our own institution over a 20-year period included 13
cases total. Benign tumors included insulinoma and mucinous cysta-
denoma. Malignant tumors included pancreatic ductal adenocarci-
noma, acinar tumor, papillary solid tumor, pancreatoblastoma, and
rhabdomyosarcoma [2]. We report a case of a 4-year old boy with a
multicystic adenomatoid pancreatic hamartoma, an extremely rare
tumor with only 4 other pediatric cases reported in the literature [3–6].
2. Case presentation
A 4-year old boy presented with an 8-month history of abdominal
pain, steatorrhea, hematochezia, and failure to thrive. He had no sig-
nificant past medical or surgical history. There was no family history of
pancreatic masses or other gastrointestinal malignancies. Labs were
notable for both iron deficiency anemia and vitamin E deficiency. Stool
analysis showed an increase in fecal fat and low fecal elastase. A
Meckel's scan was performed and was negative. He underwent an EGD
for pancreatic enzyme stimulation testing which showed a large, ul-
cerated, hypervascular mass in the second portion of the duodenum
(Fig. 1). Biopsy was not performed due to hypervascularity and concern
for hemorrhage. Computed tomography of the abdomen and pelvis
demonstrated a large, multicystic, multiseptated mass in the right upper
quadrant (Fig. 2a) with marked pancreatic atrophy (Fig. 2b). Magnetic
resonance cholangiopancreatography (MRCP) showed an 8.8 cm mass
originating in the head of the pancreas with associated mass effect on
the duodenum (Fig. 3). Laboratory findings showed normal liver and
renal function. Pancreatic enzymes were normal. AFP, beta-HCG, and
gastrin were within normal limits. CA 19–9 and uric acid were mildly
elevated (58 Units/L, 302 Units/L, respectively).
Given the obstructing nature of the mass and severe pancreatic
atrophy, he was scheduled for a classic pancreaticoduodenectomy.
Provisional diagnoses included solid pseudopapillary tumor, pancrea-
toblastoma, and intraductal papillary mucinous neoplasm. At lapar-
otomy, we noted a large cystic mass in the head of the pancreas without
evidence of metastatic disease. There were large lymph nodes in the
porta hepatis and these were resected. The common bile duct was de-
compressed and adherent to the portal vein. In dissecting the duct, an
injury to the portal vein occurred which necessitated portal vein re-
construction. The anastomoses was performed in an end-to-end fashion
with multiple 6–0 prolene sutures. After resection of the specimen,
reconstruction was completed via a retrocolic end-to-side gastro-
jejunostomy, an end-to-side hepaticojejunostomy, and a two-layer
pancreaticojejunostomy (Fig. 4).
Two 10mm drains were placed. The patient tolerated the procedure
well and was admitted to the ICU post-operatively for hemodynamic
monitoring. His post-operative course was marked by slow return of
bowel function, and erythromycin was started. He was discharged on
post-op day 11. He completed his 1 month post-operative follow-up and
is doing well.
The specimen was assessed by 3 different institutions. The lesion
appeared to originate in the head of the pancreas and measured
9.5×8.5× 8.5 cm and severely compressed the duodenum (Fig. 5).
The multiloculated cystic structure contained clear mucinous fluid with
a clear lining. There was an anomalous junction between the common
bile duct and the pancreatobiliary ductal system. Residual pancreatic
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tissue showed atrophy from obstruction. Histopathologic analysis
showed a benign appearing lesion with a mixture of bland epithelium
with gastric and biliary differentiation with dense stroma (Fig. 6). All
lymph nodes were negative for tumor.
3. Discussion
Due to the rarity of pancreatic tumors in children, there is little
available data in the literature and developing an evidence-based ap-
proach to treatment remains challenging. Incidence of pediatric pan-
creatic tumors is estimated at 0.018 per 100,000 [7]. The differential
for pediatric pancreatic tumors is broad and is comprised of epithelial
tumors, non-epithelial tumors, pancreatoblastomas, endocrine tumors,
solid pseudopapillary (Frantz) tumors, acinar cell carcinomas, sar-
comas, and lymphomas [8]. Symptoms can vary based on the size and
location of the tumor. Given the rare nature of these tumors and their
significant heterogeneity in children, our understanding remains poor
and there has been significant effort to develop prospective studies to
better understand this disease process [9].
Four additional cases of multicystic adenomatoid hamartoma of the
pancreas are reported in the literature [3–6]. Variations in patient
presentation, tumor size and location are summarized in Table 1. Three
out of five cases were male, two were female. Age ranged from 34
weeks to 4 years. Symptoms varied and included abdominal pain, dis-
tention, and steatorrhea. While other pancreatic tumors are associated
with genetic syndromes such as Beckwith-Wiedemann syndrome [10],
none of the patients were known to have a hereditary syndrome. Two
out of the five patients had laboratory values consistent with pancrea-
titis. Our patient had a mildly elevated CA 19–9, other tumor markers
were normal. It is not clear if elevated CA 19–9 is associated with
multicystic adenomatoid hamartoma, as markers were only available in
one other case report and were normal. Size of the tumor varied from 3
to 14 cm. Three out of the five tumors were located in the head of the
pancreas, one was located in the tail, and the remaining tumor was
diffusely present throughout the pancreas. Three of the five patients
underwent a Whipple operation, while the remaining underwent local
resection. While adjuvant therapy is often required for many pancreatic
tumors such as pancreatoblastomas [11,12], the reported patients with
Fig. 1. EGD demonstrating ulcerated and hypervascular mass invading second
portion of duodenum.
Fig. 2. (a) CT Abdomen and Pelvis axial demonstrating large multiseptated cystic mass in the right-upper quadrant. (b) coronal section showing accompanying
atrophy in the tail of the pancreas.
Fig. 3. Abdominal MRCP T2 weighted image demonstrating large cystic mass
with compression of duodenum, which is seen wrapping around the mass.
Pancreatic duct is not visualized.
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multicystic adenomatoid hamartoma did not undergo any type of ad-
juvant chemotherapy or radiation. Only one patient did not survive (34
week old female) who had a prolonged hospital course due to pul-
monary disease, metabolic issues, and hepatic dysfunction. The patient
ultimately passed away 3 months after surgery.
The most distinguishing feature of our case was the significant amount
of time from development of symptoms to diagnosis. The child first pre-
sented with encopresis and steatorrhea. This was likely due to both the
large size of the tumor and the location in the head of the pancreas,
causing pancreatic atrophy and resultant exocrine insufficiency. He re-
mains on pancreatic enzymes at this time. Fortunately there was enough
remnant glad remaining after resection, and the child does not currently
have any needed for insulin or evidence of endocrine insufficiency.
4. Conclusion
Multicystic adenomatoid pancreatic hamartoma is an extremely rare
benign tumor and should be in the differential diagnosis of cystic
pancreatic masses in children. Patients can present with abdominal
Fig. 4. Illustration demonstrating classic pancreaticoduodenectomy before and after specimen removal.
Fig. 5. Gross specimen showing multiseptated, multicystic mass compressing
the duodenum.
Fig. 6. Left: Low-power field demonstrating large cysts lined with ductal epithelium. Right: Low-power field showing differentiated gastric epithelium surrounded by
dense stroma (hematoxylin and eosin x10).
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pain, pancreatic exocrine insufficiency, and pancreatitis. Treatment of
choice includes surgical resection, with tumor location determining
type of surgery performed.
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Table 1
Current reported cases of pediatric pancreatic multicystic adenomatoid hamartoma.
Case Ref. Year Age Sex Symptoms Pancreatitis Location Size Surgery
1 3 2007 3 y M Abdominal pain Yes Head 3 cm Whipple
2 4 2009 14m M Abdominal pain Yes Tail 14 cm Local resection
3 5 1992 20m F Abdominal pain No Head 9 cm Local resection
4 6 1983 34 w F Abdominal distention, hypoglycemia No Diffuse 11.5 cm Whipple + splenectomy
5 Present 2019 4 y M Abdominal pain, steatorrhea, hematochezia No Head 9.5 cm Whipple
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